Variant report
Variant | esv3321210 |
---|---|
Chromosome Location | chr1:221804864-221805923 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554440206 | chr1:221804868-221804869 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs539484952 | chr1:221804900-221804901 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533760566 | chr1:221804905-221804906 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs80348730 | chr1:221804954-221804955 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs35485522 | chr1:221804970-221804971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12057339 | chr1:221804973-221804974 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs534219707 | chr1:221804974-221804975 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368784662 | chr1:221804981-221804982 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553300344 | chr1:221805029-221805030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573481353 | chr1:221805046-221805047 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs79389257 | chr1:221805058-221805059 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs577902567 | chr1:221805107-221805108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs115568201 | chr1:221805113-221805114 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs560371074 | chr1:221805126-221805127 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs527716015 | chr1:221805136-221805137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs549321611 | chr1:221805159-221805160 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76848037 | chr1:221805161-221805162 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561066300 | chr1:221805270-221805271 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138890614 | chr1:221805276-221805277 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs549974346 | chr1:221805321-221805322 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs371799553 | chr1:221805324-221805325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375945659 | chr1:221805353-221805354 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs534731062 | chr1:221805354-221805355 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142031239 | chr1:221805406-221805407 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs370157521 | chr1:221805417-221805418 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539222969 | chr1:221805425-221805426 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs375832644 | chr1:221805429-221805430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs566348761 | chr1:221805450-221805451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181970764 | chr1:221805454-221805455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575835330 | chr1:221805479-221805480 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs367841739 | chr1:221805529-221805530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs146378685 | chr1:221805530-221805531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185203778 | chr1:221805550-221805551 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139654049 | chr1:221805593-221805594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555964529 | chr1:221805603-221805604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75823013 | chr1:221805617-221805618 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs556289896 | chr1:221805620-221805621 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577939664 | chr1:221805650-221805651 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs189574352 | chr1:221805681-221805682 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560200194 | chr1:221805752-221805753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs572273699 | chr1:221805775-221805776 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74145400 | chr1:221805797-221805798 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs181225711 | chr1:221805801-221805802 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs186746675 | chr1:221805802-221805803 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs549911290 | chr1:221805810-221805811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143072388 | chr1:221805854-221805855 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs76452238 | chr1:221805890-221805891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532631102 | chr1:221805891-221805892 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs113496380 | chr1:221805916-221805917 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Autism | 14699429 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 20808228 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:221803800-221806000 | Enhancers | Primary hematopoietic stem cells | blood |
2 | chr1:221804200-221805600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr1:221804400-221805000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr1:221804400-221805200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr1:221804400-221806200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr1:221804600-221805000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr1:221804600-221805000 | Enhancers | H1 Cell Line | embryonic stem cell |
8 | chr1:221804600-221805000 | Enhancers | H9 Cell Line | embryonic stem cell |
9 | chr1:221804600-221805000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
10 | chr1:221804600-221805200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr1:221804600-221805200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr1:221804600-221806400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr1:221804600-221806400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr1:221804600-221806600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
15 | chr1:221804800-221805000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr1:221804800-221806000 | Enhancers | Fetal Heart | heart |
17 | chr1:221804800-221807600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
18 | chr1:221804800-221807600 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
19 | chr1:221805200-221805800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
20 | chr1:221805600-221805800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
21 | chr1:221805600-221805800 | Enhancers | K562 | blood |
22 | chr1:221805800-221806000 | Enhancers | HUES6 Cell Line | embryonic stem cell |